166 related articles for article (PubMed ID: 11753905)
61. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
62. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
[TBL] [Abstract][Full Text] [Related]
63. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.
Dethloff T; Tofteng F; Frederiksen HJ; Hojskov M; Hansen BA; Larsen FS
World J Gastroenterol; 2008 Apr; 14(13):2065-71. PubMed ID: 18395908
[TBL] [Abstract][Full Text] [Related]
64. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure.
Catalina MV; Barrio J; Anaya F; Salcedo M; Rincón D; Clemente G; Bañares R
Liver Int; 2003; 23 Suppl 3():39-43. PubMed ID: 12950960
[TBL] [Abstract][Full Text] [Related]
65. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure.
Sen S; Jalan R
Perfusion; 2004; 19 Suppl 1():S43-8. PubMed ID: 15161063
[TBL] [Abstract][Full Text] [Related]
66. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
[TBL] [Abstract][Full Text] [Related]
67. Clearing of toxic substances: are there differences between the available liver support devices?
Krisper P; Stadlbauer V; Stauber RE
Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
[TBL] [Abstract][Full Text] [Related]
68. Development of high-efficiency molecular adsorbent recirculating system: preliminary report.
Marangoni R; Bellati G; Castelli A; Romagnoli E
Artif Organs; 2014 Oct; 38(10):879-83. PubMed ID: 24392970
[TBL] [Abstract][Full Text] [Related]
69. First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock.
El Banayosy A; Kizner L; Schueler V; Bergmeier S; Cobaugh D; Koerfer R
ASAIO J; 2004; 50(4):332-7. PubMed ID: 15307543
[TBL] [Abstract][Full Text] [Related]
70. Review article: the molecular adsorbents recirculating system (MARS) in liver failure.
Sen S; Mookerjee RP; Davies NA; Williams R; Jalan R
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():32-8. PubMed ID: 12423451
[TBL] [Abstract][Full Text] [Related]
71. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure.
Lai WK; Haydon G; Mutimer D; Murphy N
Intensive Care Med; 2005 Nov; 31(11):1544-9. PubMed ID: 16155752
[TBL] [Abstract][Full Text] [Related]
72. Equipment review: the molecular adsorbents recirculating system (MARS).
Boyle M; Kurtovic J; Bihari D; Riordan S; Steiner C
Crit Care; 2004 Aug; 8(4):280-6. PubMed ID: 15312211
[TBL] [Abstract][Full Text] [Related]
73. Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data.
Mitzner S; Loock J; Peszynski P; Klammt S; Majcher-Peszynska J; Gramowski A; Stange J; Schmidt R
Metab Brain Dis; 2002 Dec; 17(4):463-75. PubMed ID: 12602522
[TBL] [Abstract][Full Text] [Related]
74. [Albumin dialysis MARS (Molecular Adsorbent Recirculating System) as a bridge for liver transplantation in acute liver failure. Report of three cases].
Contreras J; Poniachik J; Oksenberg D; Cortés C; Valera JM; Cotera A; Pacheco A; Segovia E; Sanhueza ME; Boltansky A; Rojas J; Guerrero J; Díaz JC
Rev Med Chil; 2004 May; 132(5):601-7. PubMed ID: 15279147
[TBL] [Abstract][Full Text] [Related]
75. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure.
Saliba F
Crit Care; 2006 Feb; 10(1):118. PubMed ID: 16542471
[TBL] [Abstract][Full Text] [Related]
76. Molecular Adsorbent Recirculating System: clinical experience in patients with liver failure based on hepatitis B in China.
Chen S; Zhang L; Shi Y; Yang X; Wang M
Liver; 2002; 22 Suppl 2():48-51. PubMed ID: 12220304
[TBL] [Abstract][Full Text] [Related]
77. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system.
Sen S; Jalan R; Williams R
Int J Biochem Cell Biol; 2003 Sep; 35(9):1306-11. PubMed ID: 12798344
[TBL] [Abstract][Full Text] [Related]
78. Albumin dialysis: single pass vs. recirculation (MARS).
Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R
Liver; 2002; 22 Suppl 2():40-2. PubMed ID: 12220302
[TBL] [Abstract][Full Text] [Related]
79. Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation.
Lee JY; Kim SB; Chang JW; Park SK; Kwon SW; Song KW; Hwang S; Lee SG
Transplant Proc; 2010 Sep; 42(7):2625-30. PubMed ID: 20832557
[TBL] [Abstract][Full Text] [Related]
80. The use of the molecular adsorbent recirculating system (MARS) albumin dialysis for the treatment of liver failure: a nursing perpective.
McCready R
Dynamics; 2009; 20(3):18-22. PubMed ID: 19953756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
